Sort
15,842 grants matching “pancreatic cancer”
Deciphering the Role of eIF5A/PEAK1 Pathway in Pancreatic Cancer
$56,978Ken Fujimura · University Of California, San Diego · F32 · FY2014 · CA
Development of Gli1-Selective Therapeutics for Hedgehog Pathway-Dependent Cancers
$56,978Alison Evelynn Ondrus · Stanford University · F32 · FY2014 · CA
Single Cell Deconvolution of the Pancreatic Tumor Microenvironment
$56,974Ki Oh · State University New York Stony Brook · F30 · FY2024 · CA
Investigation of Sox9 target genes in the pancreas
$56,906Rebecca Beer · Johns Hopkins University · F32 · FY2015 · DK
Role of MUC1 in Pancreatic Cancer
$56,860Pinku Mukherjee · Mayo Clinic Arizona · R01 · FY2008 · CA
Higher Dietary Carbohydrates Detrimentally Impact Obesity-Associated Breast Cancer Chemoresistance
$56,855Delisha A Stewart · Univ Of North Carolina Chapel Hill · R35 · FY2018 · CA
Understanding metabolic pathways that support redox homeostasis in cancer
$56,694Alexander Muir · Massachusetts Institute Of Technology · F32 · FY2017 · CA
Targeting CDK4/6 for pancreatic cancer treatment
$56,694Craig Goodwin · Univ Of North Carolina Chapel Hill · F32 · FY2017 · CA
Identification of MSKs as critical integrators of chromatin and transcription factor activation in melanoma
$56,694Douglas Barrows · Rockefeller University · F32 · FY2017 · CA
THE ROLE OF FAN1 NUCLEASE IN KIDNEY AND DIGESTIVE SYSTEM HEALTH AND FUNCTION
$56,694Ryan Richard White · Rockefeller University · F32 · FY2017 · DK
Examination of ceramide signaling in the crosstalk between pancreatic cancer cells and the tumor microenvironment
$56,694Audrey Marie Hendley · University Of California, San Francisco · F32 · FY2017 · CA
The role of neuroendocrine transdifferentiation of pancreatic cancer cells on tumor progression and chemoresistance.
$56,694Meghan Melinda Morrison Joly · Oregon Health & Science University · F32 · FY2017 · CA
Targeting hyaluronan in the tumor microenvironment to improve DNA vaccine immunotherapy
$56,694Elizabeth Kennedy Duperret · Wistar Institute · F32 · FY2017 · CA
Preclinical Translational Cancer Research Program
$56,592Min Li · University Of Oklahoma Hlth Sciences Ctr · P30 · FY2019 · CA
MYC is a critical downstream effector in KRAS-driven pancreatic cancer
$56,529Brittany Allen-Petersen · Oregon Health & Science University · F32 · FY2015 · CA
Pilot for a Multicenter Case-Control Study of Pancreatic Cancer in a High Risk r*
$56,350Paul Joseph Brennan · International Agency For Res On Cancer · R03 · FY2006 · CA
The role of p120ctn in PDAC epithelial-to-mesenchymal transition and metastasis
$56,334Jason R. Pitarresi · University Of Pennsylvania · F32 · FY2017 · CA
Clinical protocols for the treatment of gastrointestinal cancer
$56,140Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Chemical genetic investigation of metastatic seeding in pancreatic ductal adenocarcinoma using novel multiplexed in vivo screening
$56,118Christopher James Schulze · Stanford University · F32 · FY2016 · CA
Characterization of tiRNA-mediated Translational Repression
$56,118Shawn M Lyons · Brigham And Women'S Hospital · F32 · FY2016 · GM
Novel BPTES Analogs for the Treatment of Pancreatic Cancer
$56,118Sarah Zimmermann · Johns Hopkins University · F32 · FY2016 · CA
Mechanisms of tumor suppression by epigenetic regulators in pancreatic cancer
$56,042Geulah Yevgeniya Livshits · Sloan-Kettering Inst Can Research · F32 · FY2015 · CA
Two Phase Approach to Pancreatic Islet Transplantation
$56,042Bhupinder Singh Shergill · University Of California-Irvine · F32 · FY2015 · DK
Targeting Chronic Lymphocytic Leukemia with DNA Nanoparticles
$56,042Laura E Ruff · University Of California, San Diego · F32 · FY2015 · CA
The Characterization of the New Tumor Suppressor USP9X in Pancreatic Cancer
$56,042Chang-Il Hwang · Cold Spring Harbor Laboratory · F32 · FY2015 · CA